Achilles’ US IPO closed with proceeds of $175m
The Cancer Research UK spinout is developing precision T cell therapies to treat multiple cancers
Read More
Tag: Achilles Therapeutics
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
